Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent

Autor: Lucas W. E. Starmans, Nynke M. S. van den Akker, Daniel G. M. Molin, Leonie E. M. Paulis, Gustav J. Strijkers, Igor Jacobs, Klaas Nicolay, Tessa Geelen
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Pathology
Contrast Media
Medicine (miscellaneous)
Pharmaceutical Science
Gadolinium
02 engineering and technology
SDG 3 – Goede gezondheid en welzijn
Applied Microbiology and Biotechnology
Mice
Drug Delivery Systems
Immune Regulation [NCMLS 2]
Leukocytes
0303 health sciences
ICAM-1
Liposome
medicine.diagnostic_test
Intercellular Adhesion Molecule-1
021001 nanoscience & nanotechnology
Magnetic Resonance Imaging
Molecular Imaging
medicine.anatomical_structure
lcsh:R855-855.5
Molecular Medicine
medicine.symptom
Shear Strength
0210 nano-technology
medicine.medical_specialty
lcsh:Medical technology
Endothelium
MRI contrast agent
lcsh:Biotechnology
Biomedical Engineering
Inflammation
Bioengineering
Molecular MRI
Cell Line
03 medical and health sciences
SDG 3 - Good Health and Well-being
In vivo
lcsh:TP248.13-248.65
medicine
Animals
030304 developmental biology
Shear stress
Tumor Necrosis Factor-alpha
business.industry
Research
Endothelial Cells
Magnetic resonance imaging
Leukocyte
Immunoglobulin G
Liposomes
Biophysics
Stress
Mechanical

business
Zdroj: Journal of Nanobiotechnology, 10, 25-25
Journal of Nanobiotechnology, Vol 10, Iss 1, p 25 (2012)
Journal of Nanobiotechnology, 10, 1, pp. 25-25
Journal of Nanobiotechnology, 10, 1-12. BioMed Central
Journal of Nanobiotechnology
ISSN: 1477-3155
Popis: Background The upregulation of intercellular adhesion molecule-1 (ICAM-1) on the endothelium of blood vessels in response to pro-inflammatory stimuli is of major importance for the regulation of local inflammation in cardiovascular diseases such as atherosclerosis, myocardial infarction and stroke. In vivo molecular imaging of ICAM-1 will improve diagnosis and follow-up of patients by non-invasive monitoring of the progression of inflammation. Results A paramagnetic liposomal contrast agent functionalized with anti-ICAM-1 antibodies for multimodal magnetic resonance imaging (MRI) and fluorescence imaging of endothelial ICAM-1 expression is presented. The ICAM-1-targeted liposomes were extensively characterized in terms of size, morphology, relaxivity and the ability for binding to ICAM-1-expressing endothelial cells in vitro. ICAM-1-targeted liposomes exhibited strong binding to endothelial cells that depended on both the ICAM-1 expression level and the concentration of liposomes. The liposomes had a high longitudinal and transversal relaxivity, which enabled differentiation between basal and upregulated levels of ICAM-1 expression by MRI. The liposome affinity for ICAM-1 was preserved in the competing presence of leukocytes and under physiological flow conditions. Conclusion This liposomal contrast agent displays great potential for in vivo MRI of inflammation-related ICAM-1 expression.
Databáze: OpenAIRE